Last week, the Senator from Massachusetts, Elizabeth Warren, penned a letter to the Federal Trade Commission (FTC) where she characterized recent consolidation in the pharmaceutical industry as a...
On January 24, 2024, the FDA issued a new draft guidance regarding lead levels in processed baby food meant for children under two as part of its Closer to Zero initiative. The Closer to Zero...
On January 27, 2023, the FDA issued a press release linking its new draft recommendation for updated blood donation guidelines. These updated guidelines take a more modern and individual approach to...
While several different approaches are used during clinical research, traditional biomedical research involving animal testing to develop new treatments and drugs may be a strategy of the past after the FDA Modernization Act 2.0 was signed...
Major depressive disorder (MDD) — commonly referred to as depression — affects approximately 20% of adults in the United States. MDD symptoms may include depressed mood, appetite changes,...
Across every pharmacy, grocery store, and convenience store in the United States, dietary supplements — in some shape or form — line the shelves. Many patients have the misconception that because these products are sold and...
Workforce optimization, compliance challenges, and supply chain disruptions are all issues that plague the global pharmaceutical supply chain — an essential part of the healthcare system. Because global pharmaceutical supply chain...
As the COVID-19 pandemic continues and vaccinations continue to be advanced, many patients are concerned about vaccine side effects. Multiple sources have perpetuated the misconception that COVID-19...
For many minority communities, marijuana possession and use can lead to years of incarceration for nonviolent offenses. The Biden administration has recognized that the harsh punishment around...
The opioid epidemic has persisted over the past few decades. Exacerbated by the pharmaceutical industry, this epidemic has left many struggling with opioid use disorder (OUD). Effective treatments for...
A retrospective cohort study was conducted using data from January 1, 2004, to December 31, 2018. The researchers reviewed information from the FDA and the European Medicines Agency (EMA) to determine...
In a recent court ruling, United States District Judge Reed O’Connor declared that mandated HIV PrEP coverage impedes religious freedom. This ruling provides a precedent for employers to refuse...
HRA Pharma has submitted an FDA application to allow the OTC sale of their progestin-only daily birth control pill, Opill. If this application is approved, this will be the first birth control pill...
